
Continuous Inspection Readiness Clinical Trials: Governance Expectations for Active Studies
Continuous inspection readiness in clinical trials enables sponsors and CROs to maintain real‑time oversight, contemporaneous documentation, and consistent operational control throughout active studies. By embedding inspection‑ready behaviors into daily workflows, organizations reduce compliance risk, strengthen data integrity, and respond confidently to evolving regulatory expectations.
